Propanc Biopharma PPCB
Propanc Biopharma: preliminary information statement (shareholder action already approved)
- Form
- PRE 14C
- Filed
- Period
- Importance
- Routine
- Accession
- 0001493152-22-015302
- Document
- PRE 14C
Not explained yet; the original is on EDGAR.
Preliminary information statement (shareholder action already approved)
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Cannapharmarx CPMD public float $3M, Jun 30, 2025
- MetaVia MTVA public float $3M, Jun 30, 2025
- Oragenics OGEN public float $3M, Jun 30, 2025
- Inhibitor Therapeutics INTI public float $3M, Jun 30, 2025
- PTC Therapeutics PTCT public float $3M, Jun 30, 2025